KENNEWICK, Wash., Nov. 15, 2013 (GLOBE NEWSWIRE) -- Advanced Medical Isotope Corporation ("AMIC") (OTCBB:ADMD), a company engaged in the development, production and distribution of medical isotopes, today announced that the Company will host a teleconference to discuss its Third Quarter 2013 financial results and to provide a general business update on November 18, 2013.
The live teleconference will be listen-only, followed by a question and answer session. For those unable to participate in the live teleconference, a replay will be accessible through the Company's website (www.isotopeworld.com) for two (2) days.
|Advanced Medical Isotope Corporation Q3 2013|
|Financials and General Corporate Update Conference Call|
|Date: Monday, November 18, 2013|
|Time: 8:00 am Pacific|
|Toll Free: 1-855-327-6837|
|Toll/ International: 1-412-902-6720|
About Advanced Medical Isotope Corporation
Advanced Medical Isotope Corporation (OTCBB:ADMD) is a company engaged in the development, production and distribution of medical isotopes for advanced diagnostic and therapeutic applications. AMIC's goal is to empower physicians, medical researchers, and ultimately patients by providing them with essential medical isotopes that, until recently, have not been feasible or economical, in an effort to detect and cure human disease. For more information, please visit our website, www.isotopeworld.com
The Advanced Medical Isotope Corporation logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=5139
Safe Harbor Statement
This release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. You can identify these statements by the use of the words "may," "will," "should," "plans," "expects," "anticipates," "continue," "estimates," "projects," "intends," and similar expressions. Forward-looking statements involve risks and uncertainties that could cause results to differ materially from those projected or anticipated. These risks and uncertainties include, but are not limited to, AMIC's ability to successfully execute its expanded business strategy, including by entering into definitive agreements with suppliers, commercial partners and customers; general economic and business conditions, effects of continued geopolitical unrest and regional conflicts, competition, changes in technology and methods of marketing, delays in completing various engineering and manufacturing programs, changes in customer order patterns, changes in product mix, continued success in technical advances and delivering technological innovations, shortages in components, production delays due to performance quality issues with outsourced components, regulatory requirements and the ability to meet them, government agency rules and changes, and various other factors beyond the Company's control.
CONTACT: Advanced Medical Isotope Corporation James C. Katzaroff (509)736-4000 6208 W. Okanogan Ave Kennewick, Washington 99336
Source:Advanced Medical Isotope Corporation